These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8403620)

  • 1. Combined use of gonadotropin-releasing hormone and its analogues for ovulation induction optimization.
    Filicori M
    Clin Obstet Gynecol; 1993 Sep; 36(3):737-43. PubMed ID: 8403620
    [No Abstract]   [Full Text] [Related]  

  • 2. Polycystic ovary syndrome: abnormalities and management with pulsatile gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs.
    Filicori M; Flamigni C; Campaniello E; Meriggiola MC; Michelacci L; Valdiserri A; Ferrari P
    Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 2):1737-42. PubMed ID: 2122730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of leuprolide acetate on ovulation induction with human menopausal gonadotropins in polycystic ovary syndrome.
    Dodson WC; Hughes CL; Whitesides DB; Haney AF
    J Clin Endocrinol Metab; 1987 Jul; 65(1):95-100. PubMed ID: 2953752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjusting the dose to the individual response of the patient during the induction of ovulation with pulsatile gonadotropin-releasing hormone.
    Mais V; Melis GB; Strigini F; Antinori D; de Ruggiero A; Fioretti P
    Fertil Steril; 1991 Jan; 55(1):80-5. PubMed ID: 1898894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovulation induction with pulsatile luteinizing releasing hormone in women with clomiphene citrate-resistant polycystic ovary-like disease: clinical results.
    Burger CW; Korsen TJ; Hompes PG; van Kessel H; Schoemaker J
    Fertil Steril; 1986 Dec; 46(6):1045-54. PubMed ID: 3096792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovulation induction with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression by gonadotropin releasing hormone agonist in polycystic ovary disease. A cross-over study.
    Fulghesu AM; Lanzone A; Guida C; Nicoletti MC; Rossi P; Le Donne M; Caruso A; Mancuso S
    J Reprod Med; 1992 Oct; 37(10):834-40. PubMed ID: 1479563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of pulsatile gonadotropins and gonadotropin releasing hormone analogues for ovulation induction in chronic anovulatory patients].
    Bacchi Modena A; Vadora E; Fiaschetti D; Chiavazza F; Gramellini D
    Minerva Ginecol; 1988 Aug; 40(8):457-60. PubMed ID: 3063999
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of combined exogenous gonadotropins and pulsatile gonadotropin-releasing hormone in patients with polycystic ovarian disease: a new approach to induction of ovulation.
    Venturini PL; Remorgida V; Anserini P; De Cecco L
    Gynecol Endocrinol; 1988 Sep; 2(3):205-13. PubMed ID: 3147583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
    Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of gonadotropin-releasing hormone agonists in the treatment of hyperandrogenism.
    Rittmaster RS
    Clin Obstet Gynecol; 1993 Sep; 36(3):679-89. PubMed ID: 8403614
    [No Abstract]   [Full Text] [Related]  

  • 11. Ovarian control of pituitary sensitivity of luteinizing hormone secretion to gonadotropin-releasing hormone in women with the polycystic ovary syndrome.
    Dafopoulos K; Venetis C; Pournaras S; Kallitsaris A; Messinis IE
    Fertil Steril; 2009 Oct; 92(4):1378-1380. PubMed ID: 19467538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro fertilization treatment in patients with polycystic ovaries.
    Shulman A; Dor J
    J Assist Reprod Genet; 1997 Jan; 14(1):7-10. PubMed ID: 9013301
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of LHRH-A pretreatment in ovulation induction, using pulsatile administration of GnRH, in patients with polycystic ovaries].
    D'Amato G; Vizziello G; Fanizza G
    Minerva Ginecol; 1992 May; 44(5):257-62. PubMed ID: 1608524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of buserelin on the hormonal states in PCOD.
    Willemsen WN; Franssen AM; Rolland R; Vemer HM
    Prog Clin Biol Res; 1986; 225():377-89. PubMed ID: 3097673
    [No Abstract]   [Full Text] [Related]  

  • 15. Changing pituitary reactivity to follicle-stimulating hormone and luteinizing hormone-releasing hormone after induced ovulatory cycles and after anovulation in patients with polycystic ovarian disease.
    Blankstein J; Rabinovici J; Goldenberg M; Shaley J; Mehta A; Serr DM; Mashiach S
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1164-7. PubMed ID: 3119650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of gonadotropin-releasing hormone agonist to cause ovulation and prevent the ovarian hyperstimulation syndrome.
    Itskovitz-Eldor J; Levron J; Kol S
    Clin Obstet Gynecol; 1993 Sep; 36(3):701-10. PubMed ID: 8403616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypogonadotropic patients with ultrasonographically detected polycystic ovaries: endocrine response to pulsatile gonadotropin-releasing hormone.
    Schachter M; Balen AH; Patel A; Jacobs HS
    Gynecol Endocrinol; 1996 Oct; 10(5):327-35. PubMed ID: 8915662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in induction of ovulation.
    Franks S; Gilling-Smith C
    Curr Opin Obstet Gynecol; 1994 Apr; 6(2):136-40. PubMed ID: 8193252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of ovulation with D-Trp6-LHRH combined with purified FSH in patients with polycystic ovarian disease.
    Ayalon D; Ben-David M; Wohl R; Jaffe R; Vagman I; Eckstein N; Limor R; Comaru-Schally AM; Schally AV
    Gynecol Endocrinol; 1988 Dec; 2(4):319-30. PubMed ID: 2976573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.